Clinical trials · San Francisco, CA
Alzheimer’s disease clinical trials in San Francisco
We’re tracking 31 recruiting alzheimer’s disease studies with a site in or near San Francisco — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near San Francisco
- NCT07602582RecruitingPhase 3
Donanemab Extension Study for Alzheimer's Disease
This is a follow-up study for people who already completed a previous donanemab trial (AACM). Donanemab is a medication designed to slow cognitive decline in early Alzheimer's disease by targeting amyloid buildup in the brain.
Walnut Creek, CaliforniaAges 55 years+ - NCT07178210Recruiting
Robotic surgery for lymphatic drainage in Alzheimer's disease
This study tests a new robotic-assisted surgery to improve drainage of lymph fluid in the neck, which may help slow the progression of Alzheimer's disease. It is for people with mild to moderate Alzheimer's who have specific biomarkers.
Palo Alto, CaliforniaAges 50 years+ - NCT06976203RecruitingPhase 3
Testing karxt for thinking problems in alzheimer's
This trial tests if a combination medicine, KarXT plus KarX-EC, can help with thinking and memory problems in people with mild to moderate Alzheimer's disease. It aims to see if the treatment is safe and effective.
Palo Alto, CaliforniaAges 60–85 - NCT07573982Recruiting
Ultrasound brain treatment for early memory loss
This study tests a special ultrasound treatment that may help clear harmful brain waste linked to Alzheimer's. You would receive the treatment in six short sessions, and the researchers will check your memory and brain health to see if it helps.
Stanford, CaliforniaAges 18 years+ - NCT06052163RecruitingPhase 2
Testing bumetanide for early Alzheimer's disease
This study tests whether a water pill called bumetanide can help people with early Alzheimer's disease. It involves taking the study drug, having MRI scans, and doing memory tests to see if it slows down symptoms.
Stanford, CaliforniaAges 50–85 - NCT07011745RecruitingPhase 3
Study of KarXT for Alzheimer's Agitation
This study tests a new drug combination (KarXT + KarX-EC) to see if it can safely reduce agitation in people with Alzheimer's disease. It may help if you or your loved one has bothersome agitation that affects daily life.
Napa, CaliforniaAges 55–90 - NCT07764185RecruitingPhase 2
Recharge and support program for dementia caregivers
This study tests an online program designed to help caregivers of people with Alzheimer's or other dementias recharge and reduce stress. It may help you feel more supported and better able to handle caregiving challenges.
Campbell, CaliforniaAges 18 years+
Hear when a new Alzheimer’s disease trial opens near San Francisco, CA
We’ll email you when one opens near San Francisco, CA — at most once a week, no account needed, unsubscribe anytime.
Alzheimer’s disease trials in other cities
Where these studies are running near San Francisco
Institutions with a site for the recruiting alzheimer’s disease studies listed above.
- Stanford University · 2 studies
- Infectious Disease Doctors Medical Group, APC
- Local Institution - 2627
- Photozig, Inc.
- Stanford Health Care
- Stanford Neuroscience Health Center
What taking part in a alzheimer’s disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting alzheimer’s disease studies in California.
Common questions
- Are there alzheimer’s disease clinical trials near San Francisco?
- Yes. We're currently tracking 31 recruiting alzheimer’s disease studies with a site near San Francisco, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a alzheimer’s disease study near San Francisco?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in San Francisco to take part?
- Not necessarily. These studies have a site near San Francisco, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a alzheimer’s disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New alzheimer’s disease studies open near San Francisco regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.